Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
SYNGENE
₹415.85
₹409.00
₹426.05
₹380.00
₹728.60
Markets Today
Historical Performance
As of 09-07-2026 16:23, Syngene International Ltd. share price today is ₹0, with a change of ₹-411.60 (-100.00%) from the previous close of ₹411.6. The stock opened at ₹413.55 and traded between ₹409 and ₹426.05, with a total traded volume of 1345366 shares. The company has a market capitalization of ₹17063.1 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹728.6 and ₹380, respectively.
Syngene International Ltd. valuation metrics include a P/E ratio of 53.9, EPS of ₹7.87, and book value of ₹3.50. Profitability indicators show ROE of 6.54% along with a dividend yield of 0.3%. Syngene International Ltd. has reported revenue of ₹3738.7 Cr and net profit of ₹316.7 Cr.
Syngene International Ltd. technical indicators include Day RSI at 38.79, Day MFI at 29.39, Day ADX at 14.62. Additional indicators include Commodity Channel Index (CCI) at -183.8 and Williams %R at -95.66. Momentum indicators show Day MACD at -4.91, Day MACD Signal Line at -3.44, DayATR at 13.68. Rate of Change indicators for Syngene International Ltd. include ROC125 at -35.07 and ROC21 at -2.66.
Exponential moving averages include EMA5 at ₹431.3, EMA10 at ₹435.1, EMA12 at ₹436.2, EMA20 at ₹439.5, EMA26 at ₹441.1, EMA50 at ₹444.6, EMA100 at ₹463.4, EMA200 at ₹514.6. Simple moving averages include SMA5 at ₹432.9, SMA10 at ₹435.4, SMA20 at ₹441.9, SMA30 at ₹443.8, SMA50 at ₹450, SMA100 at ₹434.9, SMA150 at ₹492.9, SMA200 at ₹530.5.
Support levels for Syngene Intl are placed at First Support ₹418.78, Second Support ₹414.87, Third Support ₹408.63. Resistance levels are seen at First Resistance ₹428.93, Second Resistance ₹435.17, Third Resistance ₹439.08. Syngene International Ltd. shareholding pattern shows promoter holding at 52.68%, FII holding at 13.91%, DII holding at 0%, public holding at 6.69%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 960 | 834.40 | 830.10 | 799.30 | 948.40 |
| Operating Expense | 675.70 | 649.70 | 652.60 | 631.20 | 638.40 |
| Operating Profit | 284.30 | 184.70 | 177.50 | 168.10 | 310 |
| Depreciation | 95.30 | 97.10 | 100.10 | 94.60 | 89.60 |
| Interest | 6.50 | 6.20 | 7.40 | 5.90 | 10.10 |
| Tax | 48.50 | 13.60 | 18 | 10.20 | 54.30 |
| Net Profit | 148.20 | 16.50 | 66.20 | 74 | 174.40 |
₹415.85
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By |
|---|
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 7.97 L | 10.63 L | 75.01% |
| Week | 8.09 L | 12.62 L | 64.07% |
| 1 Month | 6.08 L | 12.58 L | 48.28% |
| 6 Month | 7.86 L | 19.98 L | 39.33% |
Benjamin Graham Value Screen
PEG lower than Industry PEG
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 25 Jun, 2026 | 1.25 | FINAL | 26 Jun, 2026 | Equity Share |
| 27 Jun, 2025 | 1.25 | FINAL | 27 Jun, 2025 | Equity Share |
| 28 Jun, 2024 | 1.25 | FINAL | 28 Jun, 2024 | Equity Share |
| 30 Jun, 2023 | 0.5 | FINAL | 30 Jun, 2023 | Equity Share |
| 30 Jun, 2022 | 0.5 | FINAL | 01 Jul, 2022 | Equity Share |
| 30 Jun, 2022 | 0.5 | SPECIAL | 01 Jul, 2022 | Equity Share |
| 16 Jul, 2019 | 0.5 | FINAL | 17 Jul, 2019 | Equity Share |
| 17 Jul, 2018 | 1 | FINAL | 18 Jul, 2018 | Equity Share |
| 20 Jul, 2017 | 1 | FINAL | 21 Jul, 2017 | Equity Share |
| 17 Mar, 2016 | 1 | INTERIM | 19 Mar, 2016 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹2,027.20 | ₹807 | ₹1,418.10 | ₹1,625 | ₹4,508 | ₹660 |
| % Change | 2.41% | 0.84% | 0.59% | 0.81% | -0.69% | 1.95% |
| Revenue TTM (₹ Cr) | ₹1,403.18 | ₹642.26 | ₹649.50 | ₹1,421.59 | ₹935 | ₹4,359.02 |
| Net Profit TTM (₹ Cr) | ₹185.12 | ₹172.89 | ₹115.38 | ₹-73.80 | ₹257.90 | ₹255.19 |
| PE TTM | 65.70 | 53.00 | 54.20 | -252.70 | 41.10 | 40.10 |
| 1 Year Return | 87.27 | 36.75 | 136.79 | -18.59 | -14.34 | 14.03 |
| ROCE | 31.54 | 24.22 | 15.60 | 0.59 | - | 11.40 |
Innova Captab Ltd.
₹ 992.00
+0.93%
Blue Jet Healthcare Ltd
₹ 575.75
+2.32%
Concord Biotech Ltd.
₹ 1311.20
+4.08%
Aarti Pharmalabs Ltd.
₹ 704.00
+2.59%
Supriya Lifescience Ltd.
₹ 876.50
+1.72%
Alivus Life Sciences Ltd.
₹ 1145.90
+1.40%
Cohance Lifesciences Ltd.
₹ 441.00
+2.37%
Eris Lifesciences Ltd.
₹ 1430.00
+0.99%
Alembic Pharmaceuticals Ltd.
₹ 816.00
+0.58%
Sun Pharma Advanced Research Company Ltd.
₹ 278.05
+2.99%
Strides Pharma Science Ltd.
₹ 1072.00
-0.81%
FDC Ltd.
₹ 431.70
+1.96%
Shilpa Medicare Ltd.
₹ 624.80
+4.95%
Jubilant Pharmova Ltd.
₹ 972.00
+0.13%
Natco Pharma Ltd.
₹ 961.55
-0.49%
Caplin Point Laboratories Ltd.
₹ 2626.00
+3.86%
Marksans Pharma Ltd.
₹ 278.80
+5.83%
Orchid Pharma Ltd.
₹ 1050.00
+4.76%
Bliss GVS Pharma Ltd.
₹ 526.90
+2.72%
Sanofi India Ltd.
₹ 3349.00
-0.96%
Procter & Gamble Health Ltd.
₹ 6600.00
+5.39%
Jeena Sikho Lifecare Ltd.
₹ 590.00
+4.71%
By signing up I certify terms, conditions & privacy policy